Dendreon Corp fka DNDNQ

[rancherho]

ocyanblue;

If DNDN loses its Motion to Dismiss and discovery commences in the class action lawsuit, many unpleasant facts may come out. IMO, the probability that croumagnon's belief that the failure of the FDA preapproval inspection and the FDA's assessment of the time that DNDN would require to correct the problems was a major factor in not accepting the Advisory Committee's recommendation for conditional approval and was a major factor in the FDA asking for more Provenge efficacy data from the ongoing IMPACT trial. If DNDN wins its motion, we'll prbably never know whether or not this was true. OTOH, if it is true and the manufacturing issues were serious and hidden from shareholders (as they continue to be), wouldn't you agree that this is something that shareholders deserve to know?